Effect of Time Interval between Breast-Conserving Surgery and Radiation Therapy on Outcomes of Node-Positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide Followed by Taxane

Hyeon-Kang KOH; Kyung-Hwan SHIN; Kyubo KIM; Eun-Sook LEE; In-Hae PARK; Keun-Seok LEE; Jungsil RO; So-Youn JUNG; Seeyoun LEE; Seok-Won KIM; Han-Sung KANG; Eui-Kyu CHIE; Wonshik HAN; Dong-Young NOH; Kyung-Hun LEE; Seock-Ah IM; Sung-Whan HA.
Cancer Research and Treatment ; : 483-490, 2016.
Artículo en Inglés | WPRIM | ID: wpr-72549

Documentos relacionados

  1. Retrasos en el tratamiento del cáncer de mama: una enfermedad peligrosa.
  2. Association of patient factors with time to treatment for breast cancer.
  3. Association of Medicaid Expansion with Reduction in Racial Disparities in the Timely Delivery of Upfront Surgical Care for Patients With Early-Stage Breast Cancer.
  4. Association of Race, Ethnicity, Language, and Insurance with Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital.
  5. Racial Disparities in Time to Treatment Persist in the Setting of a Comprehensive Breast Center.
  6. Reducing time to treatment and patient costs with breast cancer: the impact of patient visits.
  7. Breast cancer time to treatment in Martinique: predictive factors and effect on survival.
  8. ASO Author Reflections: Increasing Time of Diagnosis to Breast Cancer Surgery.
  9. Time to Adjuvant Radiotherapy in Breast Cancer Affects Survival: Implications for the American College of Surgeons Commission on Cancer Quality Metrics.
  10. Factors that Influence Treatment Delay for Patients with Breast Cancer.